• Sangamo Therapeutics (NASDAQ:SGMO) Earns "Buy" Rating from HC Wainwright

    Source: Buzz FX / 27 Jan 2025 07:55:18   America/Chicago


    Sangamo Therapeutics (NASDAQ:SGMO) Earns "Buy" Rating from HC Wainwright Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Sangamo Therapeutics ( NASDAQ:SGMO - Get Free Report ) 's stock had its "buy" rating restated by
    Read more...
Share on,